bioMetric Holdings, Inc.
Developing a disruptive long-term micro optical sensor providing user with real time qualitative & quantitative glucose info on demand
- Stage Product In Development
- Industry Biotechnology
- Location Portland, OR, USA
- Currency USD
- Founded January 2012
- Employees 4
Company Summary
Developing a user-friendly optical glucose sensor dwelling in the dermis for 29 days (1st gen). Device, proven in animals, indicates qualitative glucose based on color seen through the skin, or on quantitative basis with smart phone app & camera imaging site, displaying data on screen, storing data in the cloud, and providing user painless means to manage diabetes any time of day, or continuously, thus facilitating management of diabetes.
Team
-
Richard Guy Sass, FRSAChairman,CEO & President
Serial product development and manufacturing Entrepreneur with 48 years experience guiding innovative technology companies from inception to exit, primarily medical electronics.Past 19 years focused on diabetes industry. Directed over $150 million in exits with 3 companies, most recent exit to Bayer Healthcare. Successful application engineering and technology transfer negotiation for technologies addressing large unmet needs in Healthcare.
-
Jane Karen Conner, CPA, MBAChief Financial Officer
Proven track record in operational leadership and financial management during her
34-year career, which includes both entrepreneurial and highly-structured environments, including 19 years as a financial executive in the Diabetes industry. Significant experience with strategic planning and business development. Upon acquisition, led integration of start-up co into Bayer. Skilled in IP mgmt, contracts admin & forecasting incl $138 million in exit -
Mihailo V. Rebec, PhDChief Technology Officer
Over 30 years of medical device R&D, including 20+ as Sr. Scientist in advanced technology group of Bayer. Expertise in analytical methods related to development of medical diagnostics, early phase product research, infrared analysis, quality control, data analysis, algorithm development, instrumentation development, regulatory issues, regulatory submissions including FDA, clinical testing and studies, design of animal studies, ACLAC submissions
Previous Investors
-
Richard G. SassUnconfirmedJane K. ConnerUnconfirmedMihailo V. RebecUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.